The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in...
Read moreCancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated outside the hospital setting. Yet many patients fail to take their medication...
Read moreInspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It Already Does That” highlighting our FDA cleared ID-Cap™ System. We are...
Read more“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite easily and be engaged with the system.” – Dr. Jose Castillo-Mancilla, MD, Physician and Clinical...
Read moreA study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine program (DMP) on medication adherence (Proteus Digital Health) in a population at risk for...
Read moreOur CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote...
Read moreetectRx hosted an Xtalks Webinar on December 3: “Better Connections with Patients Using Data from Digital Pills.” Susan Baumgartner, VP of Product Management and Regulatory Affairs at etectRx, started the discussion speaking about medication...
Read more“I felt confident that the digital pill was safe, I knew it was effective. I didn’t have to worry about whether I could remember taking it and truly, it changed the way I approached my own health” – Court, 31 You asked...
Read moreCEO Valerie Sullivan spoke with Orlando Medical News about how her pharma experience will benefit etectRx as it continues to innovate medication adherence. Full Story
Read moreLate last week, we launched the first-ever virtual, multi-pill clinical trial to evaluate our ID-Cap™ System’s next-generation ingestible sensor, the ID-Tag 1.6. The ID-Cap System will allow our clinicians to utilize telehealth to remotely...
Read moreThe term digital pills might just sound like the latest hype from Silicon Valley – but it isn’t. The first of such devices dates back to 1957, and the technology had been developing since. The fall of healthcare startup unicorn Proteus (of...
Read moreIn this video webcast, etectRx’s own Dr. Susan Baumgartner, Vice President of Product Management & Regulatory Affairs, and Dr. Peter Chai, Emergency Medicine, Medical Toxicology at Brigham and Women’s Hospital, discuss how digital pills can...
Read more